Diabetic Retinopathy Stages: Understanding Your Diagnosis
The Stages of Diabetic Retinopathy
Diabetic retinopathy is a progressive eye condition that develops when high blood sugar damages the small blood vessels in your retina, the light-sensitive tissue at the back of your eye. According to the CDC's Vision and Eye Health Surveillance System, an estimated 9.6 million Americans were living with diabetic retinopathy in 2021, affecting roughly 1 in 4 people with diabetes in the U.S. (CDC VEHSS, 2023). If you have received a diagnosis of diabetic retinopathy, understanding the specific stage of the disease is one of the most important steps toward protecting your vision. At Greenwich Ophthalmology Associates, our diabetic eye care specialist uses a well-established classification system to determine how far the condition has progressed and which treatments may help.
Diabetic retinopathy is classified using an internationally recognized grading system originally developed through the Early Treatment Diabetic Retinopathy Study (ETDRS). The two overarching categories are nonproliferative diabetic retinopathy (NPDR) and proliferative diabetic retinopathy (PDR). NPDR is the earlier phase, in which damaged blood vessels begin to leak or become blocked but no new abnormal vessels have formed. PDR is the more advanced phase, defined by the growth of fragile new blood vessels on the retina or optic disc, a process called neovascularization.
Our diabetic eye care specialist evaluates the stage of diabetic retinopathy during a comprehensive dilated eye exam. By examining the retina through a widened pupil and using advanced imaging tools such as optical coherence tomography (OCT) and fluorescein angiography, we can identify specific changes like microaneurysms, hemorrhages, and areas of reduced blood flow. These findings are then compared against established clinical criteria to assign a stage and guide the next steps in your care.
Mild Nonproliferative Diabetic Retinopathy
Mild NPDR is the earliest detectable stage of diabetic retinopathy. It is often discovered during a routine diabetic eye screening before any symptoms appear. At this stage, small balloon-like swellings called microaneurysms develop in the tiny blood vessels of the retina. Microaneurysms are the hallmark of mild NPDR and are often the only visible finding. These small outpouchings may leak small amounts of fluid or blood into the surrounding retinal tissue, but the changes are limited.
Most people with mild NPDR notice no change in their vision at all. The condition is typically detected only through a dilated eye exam, which is why annual screening is so important for anyone living with diabetes. In rare instances, you may notice subtle fluctuations in your vision, but these are usually related to blood sugar swings rather than permanent retinal damage.
If you are diagnosed with mild NPDR, the primary goal is to slow or prevent progression. This involves optimizing your blood sugar, blood pressure, and cholesterol levels in close collaboration with your primary care doctor or endocrinologist. Our diabetic eye care specialist will typically recommend a follow-up dilated exam every 12 months, though your individual schedule may vary depending on other risk factors.
How Moderate NPDR Differs from Severe NPDR
As diabetic retinopathy progresses beyond the mild stage, the nature and extent of retinal damage increase significantly. In moderate NPDR, the retinal blood vessel damage extends beyond isolated microaneurysms. You may have dot-and-blot hemorrhages (small areas of bleeding within the retina), cotton wool spots (white patches caused by localized nerve fiber damage), hard exudates (yellowish lipid deposits), or mild venous beading in one quadrant. These changes indicate that blood flow to portions of the retina is becoming compromised. Patients with moderate NPDR are typically monitored every six to eight months.
Severe NPDR is identified using a clinical guideline known as the 4-2-1 rule. Your diabetic eye care specialist will classify the disease as severe if any one of the following criteria is met: severe intraretinal hemorrhages (20 or more) in each of all four retinal quadrants, definite venous beading in two or more quadrants, or prominent intraretinal microvascular abnormalities (IRMA) in one or more quadrants. Research from the ETDRS showed that eyes with severe NPDR have roughly a 50 percent chance of developing high-risk proliferative changes if left untreated.
While patients with moderate NPDR are typically seen every six to eight months, those with severe NPDR may need appointments every two to four months. In some cases, our diabetic eye care specialist may recommend panretinal laser photocoagulation for severe NPDR to reduce the risk of progression to PDR. The boundary between moderate and severe is one of the most clinically important thresholds in diabetic eye care.
Proliferative Diabetic Retinopathy
Proliferative diabetic retinopathy is the most advanced stage of the disease and carries the greatest risk of serious vision loss. PDR occurs when widespread retinal blood vessel damage triggers the growth of new, abnormal blood vessels on the surface of the retina or the optic disc. This neovascularization is the eye's attempt to restore blood flow to oxygen-deprived areas, but the new vessels are extremely fragile, poorly formed, and prone to bleeding. Neovascularization may also develop on the iris or in the drainage angle of the eye, which can lead to a particularly aggressive form of glaucoma called neovascular glaucoma.
The fragile new blood vessels can rupture and bleed into the vitreous (the gel-like substance filling the center of the eye), causing a vitreous hemorrhage that may severely blur or block your vision. Over time, scar tissue associated with neovascularization can contract and pull the retina away from its normal position, resulting in a tractional retinal detachment. Both vitreous hemorrhage and tractional detachment are serious complications that may require surgical intervention.
The primary treatment for PDR is panretinal photocoagulation (PRP), a form of laser therapy that targets the peripheral retina to reduce the oxygen demand driving abnormal vessel growth. Anti-VEGF injections, which are medications that block vascular endothelial growth factor, are a reasonable alternative for some patients and are also used when PDR remains active after complete PRP. If vitreous hemorrhage or tractional detachment develops, a surgical procedure called vitrectomy may be necessary to remove blood from the eye and repair the retina.
Frequently Asked Questions
Mild and moderate NPDR usually cause no noticeable vision changes, which is why many patients are surprised by their diagnosis. Severe NPDR may begin to cause blurred or fluctuating vision if swelling develops near the macula. PDR can cause sudden, significant vision loss if bleeding occurs inside the eye or the retina detaches. At any stage, diabetic macular edema (fluid buildup in the central retina) can independently reduce your central vision.
Mild NPDR is managed primarily through blood sugar optimization and annual monitoring. Moderate NPDR calls for more frequent follow-up exams, typically every six to eight months. Severe NPDR may warrant laser treatment or closer observation every two to four months, while PDR requires active treatment with panretinal laser, anti-VEGF injections, or surgery depending on the specific findings.
Some clinical evidence suggests that tightening blood sugar control can lead to partial regression of early retinal changes, particularly in mild NPDR. However, this improvement is not guaranteed and depends on many factors, including how long you have had diabetes and how well other risk factors are controlled. The most reliable strategy is to prevent further progression rather than to count on reversal.
The rate of progression varies widely from person to person. Some patients remain at the mild stage for many years, while others move from moderate to proliferative disease within months, especially if blood sugar control worsens. Pregnancy, rapid normalization of blood sugar after a period of poor control, and uncontrolled hypertension can all accelerate progression.
You should seek immediate evaluation if you experience a sudden increase in floaters, flashes of light, a dark shadow or curtain across any part of your vision, or a rapid, unexplained decline in your eyesight. These symptoms may indicate vitreous hemorrhage or retinal detachment, both of which require prompt treatment to preserve vision.
What our Patients say
4.8
Reviews
(3,408)